Rossari Biotech fixes record date for FY26 dividend of Re. 0.50
Rossari Biotech has announced Friday, July 10, 2026, as the record date for a final dividend of Re. 0.50 per equity share for the financial year ended March 31, 2026. The dividend is subject to shareholder approval at the 17th Annual General Meeting scheduled for Monday, July 20, 2026, via video conferencing. Remote e-voting will be open from July 17 to July 19, 2026.

*this image is generated using AI for illustrative purposes only.
Rossari Biotech has fixed Friday, July 10, 2026, as the record date to determine member eligibility for a final dividend of Re. 0.50 (25%) per equity share for the financial year ended March 31, 2026. The dividend is subject to shareholder approval at the upcoming Annual General Meeting (AGM). If approved, the payout will be made within 10 working days from the conclusion of the AGM, subject to tax deduction at source.
The company has scheduled its 17th AGM for Monday, July 20, 2026, at 11:00 A.M. IST via Video Conferencing. The facility for remote e-voting will be available from Friday, July 17, 2026, at 09:00 A.M. IST to Sunday, July 19, 2026, at 05:00 P.M. IST. The cut-off date for determining eligibility to vote is Monday, July 13, 2026. MUFG Intime India Private Limited has been appointed to manage the e-voting process.
Key Dates
| Event | Date |
|---|---|
| Record Date for Dividend | Friday, July 10, 2026 |
| Cut-off Date for E-voting | Monday, July 13, 2026 |
| Remote E-voting Start | Friday, July 17, 2026 at 09:00 A.M. IST |
| Remote E-voting End | Sunday, July 19, 2026 at 05:00 P.M. IST |
| 17th Annual General Meeting | Monday, July 20, 2026 at 11:00 A.M. IST |
The intimation was filed pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Parul Gupta, Company Secretary & Head - Legal, signed the communication on behalf of Rossari Biotech.
Historical Stock Returns for Rossari Biotech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.13% | +0.06% | +1.67% | -7.28% | -25.62% | -55.73% |
How will the proposed dividend impact Rossari Biotech's free cash flow and capital allocation plans for FY2027?
What strategic growth initiatives or CAPEX plans does the management intend to highlight during the upcoming AGM?
Will the company provide guidance on margin expansion or new product launches for the upcoming financial year?































